Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction-Reference-Cited by-同舟云学术

Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

Published:2022-05-04 Issue:10 Volume:28 Page:924-929
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Chen Yue,Xu Yu-ying,Jiang Hai-jun,Wang Lei,Zhai Jia-wei,Zhang Tong,Yang Yu-fei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11655-022-3676-7.pdf

Reference34 articles.

1. Dekker E, Tanis PJ, Vleugels J, Kasi P, Wallace M. Colorectal cancer. Lancet 2019;394:1467–1480.

2. Zheng R, Sun K, Zhang S, Zeng H, Zou X, Chen R, et al. Report of cancer epidemiology in China, 2015. China J Oncol (Chin) 2019;41:19–28.

3. Feng R, Zong Y, Cao S, Xu R. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun 2019;39:12–22.

4. Chen H, Zheng R, Wang L, Lv Z, Du L, Wei W, et al. Progress in cancer epidemiology research in China in 2019. Chin J Dis Control Prev (Chin) 2020;24:373–379.

5. Chen WQ, Li N, Lan P, Chen HD, Du LB, Sun F, et al. Expert consensus on national early diagnosis and early treatment of colorectal cancer. Nat Med J China (Chin) 2020;100:1691–1698.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine;Cancer Letters;2023-07